1,531
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Aortic stiffness and aortic-brachial stiffness mismatch as markers of renal dysfunction in hypertension

, , , , &
Pages 91-99 | Received 03 Jan 2022, Accepted 29 Mar 2022, Published online: 12 May 2022

References

  • Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–1757.
  • Hamrahian SM, Falkner B. Hypertension in chronic kidney disease. Adv Exp Med Biol. 2017;956:307–325.
  • Ronco C, Di Lullo L. Cardiorenal syndrome. Heart Fail Clin. 2014;10(2):251–280.
  • Duni A, Dounousi E, Pavlakou P, et al. Hypertension in chronic kidney disease: novel insights. Curr Hypertens Rev. 2020;16(1):45–54.
  • Sedaghat S, Mattace-Raso FU, Hoorn EJ, et al. Arterial stiffness and decline in kidney function. Clin J Am Soc Nephrol. 2015;10(12):2190–2197.
  • Schlieper G, Schurgers L, Brandenburg V, et al. Vascular calcification in chronic kidney disease: an update. Nephrol Dial Transplant. 2016;31(1):31–39.
  • Paoletti E, De Nicola L, Gabbai FB, et al. Associations of left ventricular hypertrophy and geometry with adverse outcomes in patients with CKD and hypertension. Clin J Am Soc Nephrol. 2016;11(2):271–279.
  • Townsend RR, Anderson AH, Chirinos JA, et al. Association of pulse wave velocity with chronic kidney disease progression and mortality: findings from the CRIC Study (Chronic Renal Insufficiency Cohort). Hypertension. 2018;71(6):1101–1107.
  • Ford ML, Tomlinson LA, Chapman TP, et al. Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension. 2010;55(5):1110–1115.
  • Peralta CA, Jacobs DR, Jr., Katz R, et al. Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA). American Journal of Kidney Diseases. 2012;59(1):41–49.
  • Madero M, Peralta C, Katz R, et al. Association of arterial rigidity with incident kidney disease and kidney function decline: the health ABC study. CJASN. 2013;8(3):424–433.
  • van Varik BJ, Vossen LM, Rennenberg RJ, et al. Arterial stiffness and decline of renal function in a primary care population. Hypertens Res. 2017;40(1):73–78.
  • Utescu MS, Couture V, Mac-Way F, et al. Determinants of progression of aortic stiffness in hemodialysis patients: a prospective longitudinal study. Hypertension. 2013;62(1):154–160.
  • Fortier C, Mac-Way F, Desmeules S, et al. Aortic-brachial stiffness mismatch and mortality in dialysis population. Hypertension. 2015;65(2):378–384.
  • Woodard T, Sigurdsson S, Gotal JD, et al. Mediation analysis of aortic stiffness and renal microvascular function. J Am Soc Nephrol. 2015;26(5):1181–1187.
  • Kim ED, Tanaka H, Ballew SH, et al. Associations between kidney disease measures and regional pulse wave velocity in a large community-based cohort: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis. 2018;72(5):682–690.
  • Wilkinson IB, Mäki-Petäjä KM, Mitchell GF. Uses of arterial stiffness in clinical practice. Arterioscler Thromb Vasc Biol. 2020;40(5):1063–1067.
  • Boutouyrie P, Lacolley P, Briet M, et al. Pharmacological modulation of arterial stiffness. Drugs. 2011;71(13):1689–1701.
  • Laurent S, Chatellier G, Azizi M, et al. SPARTE study: normalization of arterial stiffness and cardiovascular events in patients with hypertension at medium to very high risk. Hypertension. 2021;78(4):983–995.
  • Safar ME. Arterial stiffness as a risk factor for clinical hypertension. Nat Rev Cardiol. 2018;15(2):97–105.
  • Jekell A, Kalani M, Kahan T. The effects of alpha 1-adrenoceptor blockade and angiotensin converting enzyme inhibition on central and brachial blood pressure and vascular reactivity: the doxazosin-ramipril study. Heart Vessels. 2017;32(6):674–684.
  • Lundwall K, Jörneskog G, Jacobson SH, et al. Paricalcitol, microvascular and endothelial function in non-diabetic chronic kidney disease: a randomized trial. Am J Nephrol. 2015;42(4):265–273.
  • Ekholm M, Jekell A, Wallén NH, et al. Effects of angiotensin-converting enzyme inhibition and alpha 1-Adrenergic receptor blockade on inflammation and hemostasis in human hypertension. J Cardiovasc Pharmacol. 2018;71(4):240–247.
  • Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588–2605.
  • Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force. J Am Coll Cardiol. 2002;39(2):257–265.
  • Jekell A, Kalani M, Kahan T. Skin microvascular reactivity and subendocardial viability ratio in relation to dyslipidemia and signs of insulin resistance in non-diabetic hypertensive patients. Microcirculation. 2022;29(2):e12747.
  • Hoffman JI, Buckberg GD. The myocardial supply: demand ratio-a critical review. Am J Cardiol. 1978;41(2):327–332.
  • Tsiachris D, Tsioufis C, Syrseloudis D, et al. Subendocardial viability ratio as an index of impaired coronary flow reserve in hypertensives without significant coronary artery stenoses. J Hum Hypertens. 2012;26(1):64–70.
  • Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–270.
  • Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321–1360.
  • Iacobaeus C, Andolf E, Thorsell M, et al. Cardiac function, myocardial mechano-energetic efficiency, and ventricular-arterial coupling in normal pregnancy. J Hypertens. 2018;36(4):857–866.
  • Hashimoto J, Ito S. Central pulse pressure and aortic stiffness determine renal hemodynamics: pathophysiological implication for microalbuminuria in hypertension. Hypertension. 2011;58(5):839–846.
  • Ben-Shlomo Y, Spears M, Boustred C, et al. Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects. J Am Coll Cardiol. 2014;63(7):636–646.
  • Kaess BM, Rong J, Larson MG, et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA. 2012;308(9):875–881.
  • Böcskei RM, Benczúr B, Müller V, et al. Oscillometrically measured aortic pulse wave velocity reveals asymptomatic carotid atherosclerosis in a middle-aged, apparently healthy population. Biomed Res Int. 2020;2020:1–7.
  • Sehestedt T, Jeppesen J, Hansen TW, et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J. 2010;31(7):883–891.
  • Townsend RR. Arterial stiffness in CKD: a review. Am J Kidney Dis. 2019;73(2):240–247.
  • Safar ME, Plante GE, Mimran A. Arterial stiffness, pulse pressure, and the kidney. Am J Hypertens. 2015;28(5):561–569.
  • Laurent S, Agabiti-Rosei C, Bruno RM, et al. Microcirculation and macrocirculation in hypertension: a dangerous cross-link? Hypertension. 2022;79(3):479–490.
  • Yu S, McEniery CM. Central versus peripheral artery stiffening and cardiovascular risk. Arterioscler Thromb Vasc Biol. 2020;40(5):1028–1033.
  • Stea F, Sgrò M, Faita F, et al. Relationship between wave reflection and renal damage in hypertensive patients: a retrospective analysis. J Hypertens. 2013;31(12):2418–2424.
  • Fortier C, Sidibé A, Desjardins MP, et al. Aortic-brachial pulse wave velocity ratio: a blood pressure-independent index of vascular aging. Hypertension. 2017;69(1):96–101.
  • Kips JG, Rietzschel ER, De Buyzere ML, et al. Evaluation of noninvasive methods to assess wave reflection and pulse transit time from the pressure waveform alone. Hypertension. 2009;53(2):142–149.
  • Westerhof BE, Guelen I, Westerhof N, et al. Quantification of wave reflection in the human aorta from pressure alone: a proof of principle. Hypertension. 2006;48(4):595–601.
  • Weber T, Wassertheurer S, Rammer M, et al. Wave reflections, assessed with a novel method for pulse wave separation, are associated with end-organ damage and clinical outcomes. Hypertension. 2012;60(2):534–541.
  • Kousios A, Kouis P, Hadjivasilis A, et al. Cardiovascular risk assessment using ultrasonographic surrogate markers of atherosclerosis and arterial stiffness in patients with chronic renal impairment: a narrative review of the evidence and a critical view of their utility in clinical practice. Can J Kidney Health Dis. 2020;7:2054358120954939.
  • Lioufas N, Hawley CM, Cameron JD, et al. Chronic kidney disease and pulse wave velocity: a narrative review. Int J Hypertens. 2019;2019:9189362.
  • Lilitkarntakul P, Dhaun N, Melville V, et al. Blood pressure and not uraemia is the major determinant of arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal co-morbidity. Atherosclerosis. 2011;216(1):217–225.
  • Verbeke FH, Pannier B, Guérin AP, et al. Flow-mediated vasodilation in end-stage renal disease. CJASN. 2011;6(8):2009–2015.
  • Kopel T, Kaufman JS, Hamburg N, et al. Endothelium-dependent and -independent vascular function in advanced chronic kidney disease. CJASN. 2017;12(10):1588–1594.
  • Ekart R, Bevc S, Hojs N, et al. Albuminuria is associated with subendocardial viability ratio in chronic kidney disease patients. Kidney Blood Press Res. 2015;40(6):565–574.
  • Ekart R, Šegula A, Hartman T, et al. Subendocardial viability ratio is impaired in highly proteinuric chronic kidney disease patients with low estimated glomerular filtration rate. Ther Apher Dial. 2016;20(3):281–285.
  • Di Micco L, Salvi P, Bellasi A, et al. Subendocardial viability ratio predicts cardiovascular mortality in chronic kidney disease patients. Blood Purif. 2013;36(1):26–28.
  • Ekart R, Bevc S, Hojs N, et al. Derived subendocardial viability ratio and cardiovascular events in patients with chronic kidney disease. Cardiorenal Med. 2019;9(1):41–50.
  • Toida T, Toida R, Yamashita R, et al. Grading of left ventricular diastolic dysfunction with preserved systolic function by the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging recommendations contributes to predicting cardiovascular events in hemodialysis patients. Cardiorenal Med. 2019;9(3):190–200.